MIPI: Summary for Molecular Insight Pharmaceutica - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 8:58am EST - Canadian Markets open in 32 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Molecular Insight Pharmaceuticals, Inc. (MIPI)

On Feb 9: 1.29 USD 0.00 (0.00%)

MORE ON MIPI

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Molecular Insight Pharmaceutica (NGM:MIPI) Delayed quote data

Last Trade:	1.29 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	1.29
Open:	N/A
Bid:	1.03 x 300
Ask:	1.32 x 2000
1y Target Est:	7.17

Day's Range:	N/A - N/A
52wk Range:	1.15 - 7.90
Volume:	0
Avg Vol (3m):	129,668
Market Cap:	32.55M
P/E (ttm):	N/A
EPS (ttm):	-2.75
Div & Yield:	N/A (N/A%)

Molecular Insight Pharmaceuticals, Inc. (MIPI)

1d 5d 3m 6m 1y 2y 5y

Add MIPI to Portfolio

Download Data

HEADLINES

•	MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD
	EDGAR Online (Wed, Jan 27)

•	Molecular Insight Announces Updates to Board of Directors
	Marketwire (Wed, Jan 27)

•	UPDATE - Molecular Insight cuts job, shares fall
	at Reuters (Mon, Jan 11)

•	Biotech's Latest Failed Trials, Missed Targets
	at Seeking Alpha (Mon, Jan 11)

•	Molecular Insight Pharmaceuticals Announces Personnel Reduction to Align Operations With Development Activities
	Marketwire (Thu, Jan 7)

•	Cashing In on Obamacare
	at Motley Fool (Thu, Dec 17)

•	Molecular Insight Pharma downgraded by Jefferies & Co
	Briefing.com (Fri, Dec 11)

•	MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibi
	EDGAR Online (Thu, Dec 3)

•	MOLECULAR INSIGHT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD
	EDGAR Online (Tue, Nov 24)

•	Molecular Insight Pharmaceuticals Announces Changes to Board
	Marketwire (Tue, Nov 24)

•	MOLECULAR INSIGHT PHARMACEUTICALS, INC. Financials
	EDGAR Online Financials (Fri, Nov 13)

More Headlines for MIPI...

ANALYST

EPS Est (next year) (Dec-09) :	-2.93
EPS Est (in 2 years) (Dec-10) :	-2.59
Avg Rec (current)*:	1.7
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Molecular Insight Pharmaceuticals, Inc., a development stage biopharmaceutical company, engages in the research, development, and commercialization of molecular imaging pharmaceuticals and radiotherapeutics primarily in the areas of oncology and c...

Full Company Profile

Add to Portfolio

Email to a Friend

•